semaglutide inyecciones para bajar de peso La semaglutida original Novo Nordisk (Wegovy) ya está disponible en Argentina el tratamiento de la obesidad y del sobrepeso Lanzan en la Argentina un

The medical world has evolved

Thats not peptide therapythats gambling with your health

Understanding the GLP-1 Revolution Now, let's pivot to the medications that have truly reshaped the landscape of medical weight loss in 2026: GLP-1 receptor agonists

Some side effects (like nausea) are dose-dependent and might be milder at low doses, but others, like how it blunts appetite, could still lead to inadequate nutrient intake or a loss of lean muscle mass (called sarcopenia) if someone is losing weight without proper diet management

These pleiotrophic effectswhere one drug influences multiple biological targetsexplain why GLP-1 agonists have shown cardiovascular benefit even in patients whose weight loss is modest